Mediwelcome Healthcare Management & Technology Inc.

HKEX:2159.HK

0.41 (HKD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 70.33570.33592.19392.19373.46273.46275.45775.45786.23186.231184.281184.281169.898169.898146.805146.80569.34169.341132.607132.60780.97380.973
Cost of Revenue 59.99359.99386.69886.69864.00964.00967.84267.84277.56977.569155.386155.386151.996151.996112.715112.71555.27555.275102.981102.98163.16563.165
Gross Profit 10.34310.3435.4955.4959.4539.4537.6157.6158.6628.66228.89628.89617.90317.90334.09134.09114.06614.06629.62629.62617.80817.808
Gross Profit Ratio 0.1470.1470.060.060.1290.1290.1010.1010.10.10.1570.1570.1050.1050.2320.2320.2030.2030.2230.2230.220.22
Reseach & Development Expenses 6.0266.0266.5466.5469.7979.79712.412.412.90712.9076.1576.1573.1913.1913.4023.4023.6043.6044.4624.4621.3331.333
General & Administrative Expenses 14.30914.30910.5210.5214.98714.9879.2479.24715.79715.79714.24314.24315.41815.41811.82111.8219.1559.1558.3138.3138.768.76
Selling & Marketing Expenses 3.633.635.4115.4115.7575.7577.777.774.9694.9693.1673.1675.0945.0942.3112.3112.8792.8791.8621.8621.3271.327
SG&A 15.62215.62219.69219.69219.87119.87118.35918.35921.12921.12914.54714.54719.56719.56715.35415.35411.32611.32612.25312.25311.06611.066
Other Expenses 00001.42602.021000000000000000
Operating Expenses 21.64821.64826.23834.36928.32428.32428.69228.69232.79132.79118.84318.84324.92924.92920.47120.47116.24916.24918.76118.76115.76615.766
Operating Income -11.305-11.305-20.743-20.743-20.215-20.215-23.144-23.144-25.374-25.3748.1928.192-4.856-4.85615.33515.335-0.864-0.86412.91212.9125.415.41
Operating Income Ratio -0.161-0.161-0.225-0.225-0.275-0.275-0.307-0.307-0.294-0.2940.0440.044-0.029-0.0290.1040.104-0.012-0.0120.0970.0970.0670.067
Total Other Income Expenses Net 0.1310.131-8.431-8.4311.1991.1991.921.921.081.081.811.81-2.352-2.352-1.91-1.91-1.42-1.42-2.005-2.005-3.331-3.331
Income Before Tax -11.174-11.174-29.174-29.174-19.016-19.016-21.224-21.224-24.294-24.29410.00210.002-7.208-7.20813.42513.425-2.284-2.28410.90710.9072.0792.079
Income Before Tax Ratio -0.159-0.159-0.316-0.316-0.259-0.259-0.281-0.281-0.282-0.2820.0540.054-0.042-0.0420.0910.091-0.033-0.0330.0820.0820.0260.026
Income Tax Expense 0.2910.2910.1510.1510.0070.0071.5291.5290.1750.1750.7310.7310.9240.9240.4320.4320.2810.2810.9160.9161.0421.042
Net Income -11.107-11.107-29.243-29.243-17.806-17.806-21.485-21.485-23.117-23.11710.2210.22-7.897-7.89711.6611.66-1.139-1.1399.1579.1571.2691.269
Net Income Ratio -0.158-0.158-0.317-0.317-0.242-0.242-0.285-0.285-0.268-0.2680.0550.055-0.046-0.0460.0790.079-0.016-0.0160.0690.0690.0160.016
EPS -0.058-0.058-0.15-0.15-0.093-0.093-0.12-0.12-0.12-0.120.0540.054-0.045-0.0450.0690.069-0.009-0.0090.0610.0610.0070.007
EPS Diluted -0.058-0.058-0.15-0.15-0.093-0.093-0.12-0.12-0.12-0.120.0540.054-0.045-0.0450.0690.069-0.009-0.0090.0610.0610.0070.007
EBITDA -10.953-10.953-20.094-19.19-16.852-16.852-22.332-21.488-22.03-22.039.3539.959-1.875-1.87515.94215.9421.5071.50714.07714.0776.2746.274
EBITDA Ratio -0.156-0.156-0.218-0.208-0.229-0.229-0.296-0.285-0.255-0.2550.0510.054-0.011-0.0110.1090.1090.0220.0220.1060.1060.0770.077